HK39591A - Injectable ready-to-use solutions containing an antitumor anthracycline glycoside - Google Patents

Injectable ready-to-use solutions containing an antitumor anthracycline glycoside Download PDF

Info

Publication number
HK39591A
HK39591A HK395/91A HK39591A HK39591A HK 39591 A HK39591 A HK 39591A HK 395/91 A HK395/91 A HK 395/91A HK 39591 A HK39591 A HK 39591A HK 39591 A HK39591 A HK 39591A
Authority
HK
Hong Kong
Prior art keywords
anthracycline glycoside
solutions containing
use solutions
antitumor anthracycline
injectable
Prior art date
Application number
HK395/91A
Other languages
English (en)
Inventor
Gatti Gaetano
Oldani Diego
Bottoni Giuseppe
Confalonieri Carlo
Gambini Luciano
De Ponti Roberto
Original Assignee
Pharmacia Italia S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK39591(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Pharmacia Italia S.P.A. filed Critical Pharmacia Italia S.P.A.
Publication of HK39591A publication Critical patent/HK39591A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK395/91A 1986-12-05 1991-05-23 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside HK39591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22

Publications (1)

Publication Number Publication Date
HK39591A true HK39591A (en) 1991-05-31

Family

ID=26291656

Family Applications (2)

Application Number Title Priority Date Filing Date
HK395/91A HK39591A (en) 1986-12-05 1991-05-23 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
HK03101548.2A HK1049440A1 (en) 1986-12-05 1998-11-30 An injectable, ready-to-use solution containing an anti-tumor anthracycline glycoside

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK03101548.2A HK1049440A1 (en) 1986-12-05 1998-11-30 An injectable, ready-to-use solution containing an anti-tumor anthracycline glycoside

Country Status (22)

Country Link
EP (4) EP0273603B1 (enExample)
JP (1) JP2621255B2 (enExample)
KR (2) KR0158672B1 (enExample)
CN (1) CN1058391C (enExample)
AT (2) ATE240108T1 (enExample)
AU (1) AU632036B2 (enExample)
BE (1) BE1000540A5 (enExample)
CH (1) CH680494A5 (enExample)
DE (4) DE3751589T2 (enExample)
DK (1) DK175815B1 (enExample)
ES (3) ES2198424T3 (enExample)
FI (1) FI91710C (enExample)
FR (1) FR2607702B1 (enExample)
GB (1) GB2200047B (enExample)
GR (2) GR871846B (enExample)
HK (2) HK39591A (enExample)
IT (1) IT1226072B (enExample)
NL (1) NL8702914A (enExample)
NO (1) NO175802C (enExample)
PT (1) PT86285B (enExample)
SE (1) SE512881C2 (enExample)
SG (1) SG36591G (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CA2446837C (en) * 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
BRPI0605832A2 (pt) * 2005-05-11 2009-05-26 Sicor Inc glicosìdeos de antraciclina liofilizados estáveis
BRPI0816364B8 (pt) * 2007-09-04 2021-05-25 Meiji Seika Kaisha solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção
EP2174651A1 (en) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) A polymer-free hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
FR2607702B1 (fr) 1991-08-16
EP0438183A1 (en) 1991-07-24
HK1011288A1 (en) 1999-07-09
AU632036B2 (en) 1992-12-17
NO875055L (no) 1988-06-06
EP0273603B1 (en) 1992-03-11
ES2198424T3 (es) 2004-02-01
FI91710B (fi) 1994-04-29
NO875055D0 (no) 1987-12-03
DE3777365D1 (de) 1992-04-16
ES2082023T3 (es) 1996-03-16
KR880007086A (ko) 1988-08-26
GR3004303T3 (enExample) 1993-03-31
NL8702914A (nl) 1988-07-01
DE3752368T2 (de) 2004-02-12
ES2039460T3 (es) 1993-10-01
CH680494A5 (enExample) 1992-09-15
SE512881C2 (sv) 2000-05-29
HK1049440A1 (en) 2003-05-16
DE3741037A1 (de) 1988-06-09
BE1000540A5 (fr) 1989-01-24
DE3752368D1 (de) 2003-06-18
DK635287D0 (da) 1987-12-03
GB2200047A (en) 1988-07-27
FI875340A0 (fi) 1987-12-03
EP0438183B1 (en) 1995-11-08
DK635287A (da) 1988-06-06
KR0158672B1 (en) 1998-12-01
NO175802C (no) 1994-12-14
GR871846B (en) 1988-04-01
PT86285A (en) 1988-01-01
FI875340L (fi) 1988-06-06
EP0659435B1 (en) 2003-05-14
JPS63215633A (ja) 1988-09-08
CN87108225A (zh) 1988-09-14
SE8704849D0 (sv) 1987-12-03
IT8722869A0 (it) 1987-12-03
GB2200047B (en) 1990-11-21
AU8205987A (en) 1988-06-09
EP1283044A3 (en) 2003-05-14
ATE129896T1 (de) 1995-11-15
IT1226072B (it) 1990-12-10
EP1283044A2 (en) 2003-02-12
SE8704849L (sv) 1988-06-06
CN1058391C (zh) 2000-11-15
EP0273603A2 (en) 1988-07-06
EP0659435A1 (en) 1995-06-28
SG36591G (en) 1991-06-21
KR960007861B1 (ko) 1996-06-13
FI91710C (fi) 1994-08-10
GB8728313D0 (en) 1988-01-06
DK175815B1 (da) 2005-03-07
FR2607702A1 (fr) 1988-06-10
ATE240108T1 (de) 2003-05-15
PT86285B (pt) 1990-11-07
DE3751589T2 (de) 1996-05-02
EP0273603A3 (en) 1988-07-20
NO175802B (no) 1994-09-05
DE3751589D1 (de) 1995-12-14
JP2621255B2 (ja) 1997-06-18

Similar Documents

Publication Publication Date Title
IL82209A0 (en) Insulin preparation
ES2033871T3 (es) Un procedimiento para producir una preparacion de insulina para administracion parenteral.
IE820136L (en) Pharmaceutical formulation
HK93990A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
EP1283044A3 (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
DE3874610D1 (enExample)
IE45070L (en) Anthracycline glycoside antibiotics
IE872589L (en) Treated lipid regulator
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
AU8213387A (en) Anthracycline derivatives having cytostatic activity
ES8701490A1 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
MY104837A (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
AU6816787A (en) (Gem-heterocyclodimethanamine-N,N') platinum complexes
GR3018867T3 (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside.
ZA879087B (en) Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
IL84703A0 (en) Injectable ready-to-use solution containing an antitumor anthracycline glycoside

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20071202